Ginkgo Bioworks Is Expanding Covid Testing Business

The video discusses the impact of COVID-19 on business, focusing on biosecurity measures like school testing. It highlights the challenges posed by the Delta variant and the importance of masks and testing in schools. The video also covers advancements in vaccine technology, partnerships with companies like Aldevron, and the role of synthetic biology in gene therapy. It concludes with a comparison of business models, emphasizing Ginkgo's tech-inspired approach and its market strategy.

How has COVID-19 testing in schools changed the approach to keeping students safe?

What are the implications of the Delta variant on school operations compared to the previous year?

Discuss the importance of weekly testing in schools during the pandemic.

What role do vaccines play in managing COVID-19 for both adults and children?

How does the business model of Ginkgo differ from other synthetic biology companies?